cobas Strep A Nucleic acid test for use on the cobas Liat System (07341911190) and 1 more
Groups A, C And G Beta-Hemolytic Streptococcus Nucleic Acid Amplification System. 510(k) K260047, from Roche Molecular Systems, Inc. (Pleasanton, CA). Product code PGX, class 2.
As of Nov 19, 2026, K260047 is an FDA 510(k) held by Roche Molecular Systems, Inc., substantially equivalent on Aug 28, 2026 after 233 days, with no recalls tied to it in FDA's recall database.
- Review time: 233 days
- Recalls: 0
The cobas Strep A nucleic acid test for use on the cobas Liat System (cobas Strep A) is a qualitative in vitro diagnostic test for the detection of Streptococcus pyogenes (Group A β-hemolytic Streptococcus, Strep A) in throat swab specimens from patients with signs and symptoms of pharyngitis.
- cobas Influenza A/B Nucleic acid test for use on the cobas Liat System, cobas Influenza A/B & RSV Nucleic acid test for…K200065 · Roche Molecular Systems, Inc. · Feb 10, 2020
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jan 7, 2026
- Review panel
- Microbiology
- Regulation
- 21 CFR 866.2680
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files